text:["Active ingredient(s): Aztreonam","Indications: For CF patients aged 6 years and older with <i> Pseudomonas aeruginosa </i> infections","Mechanism: Beta-Lactam antibiotic disrupts bacterial cell wall synthesis, leading to the death of the pathogen","Administration: Inhalation via nebulizer, taken three times daily in 28-day cycles","Approval: Approved by the EMA in 2009"]
text:["Active ingredient(s): Aztreonam",<>Indications: For CF patients aged 6 years and older with <i> Pseudomonas aeruginosa </i> infections</>,"Mechanism: Beta-Lactam antibiotic disrupts bacterial cell wall synthesis, leading to the death of the pathogen","Administration: Inhalation via nebulizer, taken three times daily in 28-day cycles","Approval: Approved by the EMA in 2009"]